These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1938289)

  • 1. Use of perfluorooctylbromide (PFOB) to detect liver abscesses with computed tomography. Safety and efficacy.
    Mattrey RF; Brown JJ; Shelton RE; Ogino MT; Johnson KK; Mitten RM
    Invest Radiol; 1991 Sep; 26(9):792-8. PubMed ID: 1938289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific enhancement of intra-abdominal abscesses with perfluoroctylbromide for CT imaging.
    Mattrey RF; Andrè M; Campbell J; Mitten R; Multer F; Hackney D; Long DM; Higgins CB
    Invest Radiol; 1984; 19(5):438-46. PubMed ID: 6511250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computed tomographic enhancement of the liver, liver abscesses, spleen, and major vessels with perfluorooctylbromide emulsion. Influence of dosage and injection velocity in an animal model.
    Adam G; Günther RW; Schiffer C; Görtz H; Prescher A; Scherer K
    Invest Radiol; 1992 Sep; 27(9):698-705. PubMed ID: 1399453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Computed tomographic studies on density kinetics after the bolus injection and infusion of perfluorooctylbromide (PFOB). Animal experimental studies].
    Adam G; Günther RW; Prescher A; Goertz H; Schiffer C; Bruchmüller K; Limmer J
    Rofo; 1992 May; 156(5):487-91. PubMed ID: 1596555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perfluoroctylbromide: a reticuloendothelial-specific and tumor-imaging agent for computed tomography.
    Mattrey RF; Long DM; Multer F; Mitten R; Higgins CB
    Radiology; 1982 Dec; 145(3):755-8. PubMed ID: 7146408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computed tomographic evaluation of an experimental model for pyogenic liver abscesses.
    Thompson WM; Stude RA; McDonald MI; Halvorsen RA; Dunnick NR; Silverman PM; Korobkin M; Durack DT; Shelbourne J
    Invest Radiol; 1985; 20(2):152-8. PubMed ID: 3886589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computed tomography of experimental liver abscesses using a new liposomal contrast agent.
    Dick A; Adam G; Tacke J; Prescher A; Southon TE; Günther RW
    Invest Radiol; 1996 Apr; 31(4):194-203. PubMed ID: 8721958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perfluoroctylbromide. Acute hemodynamic effects, in pigs, of intravenous administration compared with the standard ionic contrast media.
    Peck WW; Mattrey RF; Slutsky RA; Higgins CB
    Invest Radiol; 1984; 19(2):129-32. PubMed ID: 6533103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perfluoroctylbromide as a blood pool contrast agent for liver, spleen, and vascular imaging in computed tomography.
    Mattrey RF; Long DM; Peck WW; Slutsky RA; Higgins CB
    J Comput Assist Tomogr; 1984 Aug; 8(4):739-44. PubMed ID: 6736376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential role of PFOB enhanced sonography of the kidney. I. Detection of renal function and acute tubular necrosis.
    Munzing D; Mattrey RF; Reznik VM; Mitten RM; Peterson T
    Kidney Int; 1991 Apr; 39(4):733-9. PubMed ID: 2051731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perfluoroctylbromide: a liver/spleen-specific and tumor-imaging ultrasound contrast material.
    Mattrey RF; Scheible FW; Gosink BB; Leopold GR; Long DM; Higgins CB
    Radiology; 1982 Dec; 145(3):759-62. PubMed ID: 7146409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential role of PFOB enhanced sonography of the kidney. II. Detection of partial infarction.
    Coley BD; Mattrey RF; Roberts A; Keane S
    Kidney Int; 1991 Apr; 39(4):740-5. PubMed ID: 2051732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic imaging with iodinated nanoparticles: a comparison with iohexol in rabbits.
    Gazelle GS; Wolf GL; McIntire GL; Bacon ER; Na G; Halpern EF; Toner JL
    Acad Radiol; 1995 Aug; 2(8):700-4. PubMed ID: 9419627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental comparison of EOE-13 and perfluoroctylbromide for the CT detection of hepatic metastases.
    Patronas N; Miller DL; Girton M
    Invest Radiol; 1984; 19(6):570-3. PubMed ID: 6096289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation of liver abscess from liver metastasis using dual-energy spectral CT quantitative parameters.
    Wang N; Ju Y; Wu J; Liu A; Chen A; Liu J; Liu Y; Li J
    Eur J Radiol; 2019 Apr; 113():204-208. PubMed ID: 30927948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gas-containing liver abscesses: assessment by ultrasound (US) and computed tomography (CT).
    Samad SA; Zulfiqar MA; Maimunah A
    Med J Malaysia; 1993 Mar; 48(1):33-9. PubMed ID: 8341170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AUR Memorial Award 1990. The physiologic basis of the radiodense renal medulla after the administration of blood pool contrast agent PFOB.
    Coley BD; Mattrey RF; Mitten RM; Peterson T
    Invest Radiol; 1990 Dec; 25(12):1287-93. PubMed ID: 2279907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver, spleen, and vessels: preliminary clinical results of CT with perfluorooctylbromide.
    Bruneton JN; Falewée MN; François E; Cambon P; Philip C; Riess JG; Balu-Maestro C; Rogopoulos A
    Radiology; 1989 Jan; 170(1 Pt 1):179-83. PubMed ID: 2909093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis of bacterial hepatic abscess by CT.
    Wang CL; Guo XJ; Qiu SB; Lei Y; Yuan ZD; Dong HB; Liu HA
    Hepatobiliary Pancreat Dis Int; 2007 Jun; 6(3):271-5. PubMed ID: 17548250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [MRT of experimental liver abscesses: a comparison of a new blood pool contrast medium with gadolinium-DTPA in animal experiments].
    Dick A; Adam G; Spüntrup E; Prescher A; Mühler A; Günther RW
    Rofo; 1996 Oct; 165(4):392-7. PubMed ID: 8963054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.